XEN496

Drug identity checked against registry records

Also recorded as ezogabine; retigabine

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
An Open-Label Extension of the Study XEN496 (Ezogabine) in Children With KCNQ2-DEENCT04912856XENEPhase 3Terminated2023-11-17Actual
XEN496 (Ezogabine) in Children With KCNQ2 Developmental and Epileptic EncephalopathyNCT04639310XENEPhase 3Terminated2023-05-16Actual

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.